The hexapeptide immunofan inhibits the MRP-dependent multidrug resistance of tumor cells.
Korystov
Yu N
YN
Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino, Moscow oblast.
Lebedev
V V
VV
Shaposhnikova
V V
VV
Ermakova
N V
NV
Kublik
L N
LN
Chailakhyan
L M
LM
D000595:Amino Acid Sequence; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D045744:Cell Line, Tumor; D016572:Cyclosporine / Q000494:pharmacology; D018432:Drug Resistance, Multiple / Q000187:drug effects*; D019008:Drug Resistance, Neoplasm; D005452:Fluoresceins / Q000378:metabolism; D006801:Humans; D007822:Laryngeal Neoplasms / Q000378:metabolism; D007941:Leukemia P388 / Q000378:metabolism; D051379:Mice; D008811:Mice, Inbred DBA; D027425:ATP-Binding Cassette, Sub-Family C Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D009842:Oligopeptides / Q000737:chemistry / Q000494:pharmacology*; D020112:Rhodamine 123 / Q000378:metabolism; D014750:Vincristine / Q000494:pharmacology
D000970:Antineoplastic Agents; D016572:Cyclosporine; D005452:Fluoresceins; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D009842:Oligopeptides; D020112:Rhodamine 123; D014750:Vincristine; C080035:thymohexin; C007740:fluorexon